Abstract
dc:descriptionObjectives: Evaluation of laboratory findings (including tests for thrombophilia, lipid and autoimmunity profile) as well as, recording clinical characteristics from 56 cases of ischemic colitis (IC).Methods: Laboratory tests were evaluated in 56 cases of IC and the findings were compared with a group of 44 controls, individuals with known predisposing factors of IC but no evidence of the disease. Parameters measured were: Complete blood count, fibrinogen, coagulation, biochemical, lipidemic and autoimmune profile. Regarding to thrombophilic factors; protein C (PC), protein S (PS), antithrombin (AT), resistance to activated protein C (APCR), lupus anticoagulant (LA) and genetic factors such as, factor V G1691A mutation (FV Leiden), prothrombin 20210G/A mutation, methylenetetrahydrofolate reductase (MTHFR) gene C677T & A1298C mutations and plasminogen activator inhibitor-1 (PAI-1) gene 5G/4G & 4G/4G polymorphisms.Results: Main presenting symptoms were: abdominal pain (82.1%) and bloody diarrhea (80.4%). Schock (systolic pressure < 90 mmHg) was observed in 19.6%. The most common disease locations were rectosigmoid (42.9%) and splenic flexure (30.4%), while the prevalence of the extensive form (involving more than 1 of the other two locations) and right colon involvement were 25% and 1.8%, respectively. The mean duration of hospitalization was 5.6 ± 2.88 days. Of the 56 patients only three needed surgical treatment and one, eventually, died as a result of the disease. The absolute lymphocyte count had a tendency to be lower in the IC group (p = .080) with lymphopenia (< 1200/μl) most prevalent (χ2(2)= 7.925, p=.019). The platelet count was higher and the mean platelet volume (MPV) lower in the IC group (p = .0005 and p = .039, respectively). Hyponatremia (Na < 136 mmol/l) was more common in the IC group 19.6% vs 4.5% (χ2(2)= 7.133, p=.028). HDL cholesterol levels > 40 mg/dl were significantly more common in male patients than in male controls 76.9% vs 35.7% (χ2(1)= 6.034, p=.014), while in females, levels > 50 mg/dl tended to be more prevalent in the IC group, 60.0% vs 28.6% (χ2(1)= 3.548, p= .060). The values of apolipoprotein B (APOB) were lower (p = .028) in the same group. Significant difference was noted in the values of PT and aPTT (p = .0005 for each parameter). Prolongation of PT (> 14 sec) was most commonly observed in IC patients 67.9% vs 18.2% (χ2(1)= 24.478, p= .0005), while prolongation of aPTT (> 35 sec) was 10.7% vs 4.5%, respectively, but not significant. Patients compared to controls seem to have high prevalence of PC and AT deficiencies (p= .003, FET & χ2(1)= 4.786, p= .029, respectively), as well as elevated percentages of resistance to the action of APC (p = .030, FET) and presence of LA (p = .037, FET). Additionally, high fibrinogen levels (>440 mg/dl) were significantly more common in the IC group (χ2(1)= 15.426, p= .0005). Finally, homozygotes for MTHFR A1298C & C677T mutations tended to be more in the patients group (χ2(2)= 5.582, p = .061 & χ2(2)= 1.291, p= .525, respectively) while, the prevalence of 5G/4G & 4G/4G PAI-1 gene polymorphisms were significantly elevated in the same group, in contrast to the wild type (χ2(2)= 6.973, p = .031). No significant results arose from the neutrophils to lymphocytes ratio (N/L), the autoimmunity tests and the rest of the parameters tested.Multivariate analysis was performed to determine the effects of lipids and prothrombotic factors in IC. Increased HDL levels were associated with an increased likelihood of exhibiting IC (OR 1.119; 95% CI 1.039-1.204) and increased APOB levels were associated with a reduced probability of IC (OR 0.948; 95% CI 0.916-0.981). Furthermore, individuals with 5G/4G polymorphism were 12.29 times more likely to exhibit IC than others without the polymorphism (OR 12.29; 95% CI 2.26-67.00). For each unit reduction in the APCR the odds of having IC increases by a factor of 11.24 (OR 11.24; 95% CI 1.43-90.91), while increased fibrinogen levels were associated with an increased probability of IC (OR 1.013; 95% CI 1.003-1.023).(FET: Fischer’s Exact Test, OR: Odds ratio, CI: Confidence intervals)Conclusion: This study suggests that in IC patients, compared to individuals with known predisposing factors for IC, there is a background of hypercoagulability, both hereditary and aquired. IC, although, called “ischemic” seems to be differentiated from the cardiovascular disease (CVD). Platelets in these patients, seem, to function in a different way than in CVD and are possibly activated. Patients with IC seem to have a chronic, subclinical vitamin K deficiency. Autoimmunity has no role in the aetiology and pathophysiology of IC.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsimperidis, Achilleas
- Τσιμπερίδης, Αχιλλέας
Subjects
dc:subject × 22- Ισχαιμική κολίτιδα
- Θρομβοφιλία
- Ινωδογόνο
- Αυτοαντισώματα
- Ισχαιμική καρδιαγγειακή νόσος
- πολυμορφισμοί του PAI-1
- Υπερπηκτικότητα
- Έλλειψη βιταμίνης Κ
- Ischemic colitis
- Thrombophilia
- Fibrinogen
- APOB
- HDL
- Autoantibodies
- Ischemic cardiovascular disease
- PAI-1 gene polymorphisms
- Hypercoagulability
- Vitamin K deficiency
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35518